The Fetal Medicine Foundation algorithm combines information on risk factors, such as placental perfusion (uterine artery pulsatility index [UtA-PI] plus mean arterial pressure), clinical characteristics (maternal factors/medical history), and biomarker levels (PlGF), to estimate risk for preeclampsia. This evidence concerns the gene PGF and preeclampsia.